Impact of opinion leader–endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: A randomized controlled trial

This publication has 27 references indexed in Scilit:

• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
  The Lancet, 2005
• A cluster randomized trial to assess the impact of opinion leader endorsed evidence summaries on improving quality of prescribing for patients with chronic cardiovascular disease: rationale and design [ISRCTN26365328]
  BMC Cardiovascular Disorders, 2005
• Lipid management in patients with unstable angina pectoris and non–ST-segment elevation acute myocardial infarction (from CRUSADE)
  The American Journal of Cardiology, 2005
• Meta-Analysis: Angiotensin-Receptor Blockers in Chronic Heart Failure and High-Risk Acute Myocardial Infarction
  Annals of Internal Medicine, 2004
• From knowledge to practice in chronic cardiovascular disease: a long and winding road
  Journal of the American College of Cardiology, 2004
• The underutilization of cardiacmedications of proven benefit, 1990 to 2002
  Journal of the American College of Cardiology, 2002
• Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey
  The Lancet, 2002
• Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries
  The Lancet, 2001
• The Treatment and Prevention of Coronary Heart Disease in Canada: Do Older Patients Receive Efficacious Therapies?
  Journal of the American Geriatrics Society, 1999
• Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
  JAMA, 1995